Healthcare Intelligence
Oncology
Real-time intelligence, expert analysis, and verified research for the Oncology industry. Stay ahead in 3 minutes a day.
Stay ahead of Oncology in 3 minutes a day.
Expert-verified intelligence delivered to your inbox every morning.
Free forever. No spam. Unsubscribe anytime.
FDA Approves Merck's Keytruda for Early-Stage Lung Cancer Treatment
FDA grants approval for Keytruda as adjuvant therapy for resected NSCLC patients, expanding treatment options.
Read full articleBioNTech Reports Positive Phase 2 Results for mRNA Cancer Vaccine
BioNTech's personalized mRNA cancer vaccine shows promising efficacy in pancreatic cancer patients.
Read full articleNovartis Acquires MorphoSys for $2.9 Billion to Boost Cancer Pipeline
Novartis strengthens oncology portfolio with acquisition of MorphoSys and its blood cancer treatments.
Read full articleAI Tool Detects Breast Cancer 5 Years Before Traditional Methods
MIT researchers develop AI algorithm that predicts breast cancer risk with 90% accuracy years in advance.
Read full articleRoche's Tecentriq Fails Phase 3 Trial for Liver Cancer Treatment
Roche discontinues Tecentriq development for hepatocellular carcinoma after missing primary endpoints.
Read full articleJ&J's CAR-T Therapy Shows 95% Response Rate in Multiple Myeloma
Johnson & Johnson reports exceptional results for Carvykti in heavily pretreated myeloma patients.
Read full articleChina Approves First Domestic KRAS Inhibitor for Lung Cancer
Innovent Biologics receives approval for China's first locally developed KRAS G12C inhibitor.
Read full articlePfizer Initiates Phase 3 Trial for Next-Gen ADC in Breast Cancer
Pfizer advances antibody-drug conjugate targeting HER2-low breast cancer into late-stage testing.
Read full articleFDA Approves Merck's Keytruda for Early-Stage Lung Cancer Treatment
FDA grants approval for Keytruda as adjuvant therapy for resected NSCLC patients, expanding treatment options.
Read full articleBioNTech Reports Positive Phase 2 Results for mRNA Cancer Vaccine
BioNTech's personalized mRNA cancer vaccine shows promising efficacy in pancreatic cancer patients.
Read full articleNovartis Acquires MorphoSys for $2.9 Billion to Boost Cancer Pipeline
Novartis strengthens oncology portfolio with acquisition of MorphoSys and its blood cancer treatments.
Read full articleAI Tool Detects Breast Cancer 5 Years Before Traditional Methods
MIT researchers develop AI algorithm that predicts breast cancer risk with 90% accuracy years in advance.
Read full articleRoche's Tecentriq Fails Phase 3 Trial for Liver Cancer Treatment
Roche discontinues Tecentriq development for hepatocellular carcinoma after missing primary endpoints.
Read full articleJ&J's CAR-T Therapy Shows 95% Response Rate in Multiple Myeloma
Johnson & Johnson reports exceptional results for Carvykti in heavily pretreated myeloma patients.
Read full articleChina Approves First Domestic KRAS Inhibitor for Lung Cancer
Innovent Biologics receives approval for China's first locally developed KRAS G12C inhibitor.
Read full articlePfizer Initiates Phase 3 Trial for Next-Gen ADC in Breast Cancer
Pfizer advances antibody-drug conjugate targeting HER2-low breast cancer into late-stage testing.
Read full articleStay ahead of Oncology in 3 minutes a day.
Live opportunity intelligence for your market, delivered to your inbox every morning. Read it over coffee.
Free forever. No spam. Unsubscribe anytime.